121 related articles for article (PubMed ID: 6454613)
1. Plasma concentration of platelet-specific proteins and fibrinopeptide A in patients with artificial heart valves.
Dudczak R; Niessner H; Thaler E; Lechner K; Kletter K; Frischauf H; Domanig E; Aicher H
Haemostasis; 1981; 10(4):186-94. PubMed ID: 6454613
[TBL] [Abstract][Full Text] [Related]
2. Do malfunctioning bioprosthetic heart valves represent a potential thrombogenic focus?
Prandoni P; Pengo V; Boetto P; Zambon G; Menozzi L
Haemostasis; 1985; 15(5):337-44. PubMed ID: 2934303
[TBL] [Abstract][Full Text] [Related]
3. Platelet and coagulation function in patients with abnormal cardiac valves treated with sulphinpyrazone.
Ludlam CA; Allan N; Blandford RB; Dowdle R; Bentley NJ; Bloom AL
Thromb Haemost; 1981 Dec; 46(4):743-6. PubMed ID: 6460338
[TBL] [Abstract][Full Text] [Related]
4. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
Cadroy Y; Horbett TA; Hanson SR
J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
[TBL] [Abstract][Full Text] [Related]
5. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
6. [beta-Thromboglobulin in plasma in patients with heart-valve diseases and with prosthetic heart valves (author's transl)].
Heilmann E; Bender F; Breuer HW; Klinke F
Z Kardiol; 1980 Dec; 69(12):815-7. PubMed ID: 6169213
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
Kaplan KL; Nossel HL; Drillings M; Lesznik G
Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
[TBL] [Abstract][Full Text] [Related]
8. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
[TBL] [Abstract][Full Text] [Related]
9. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
Roy MS; Podgor MJ; Rick ME
Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
[TBL] [Abstract][Full Text] [Related]
10. Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease.
Nichols AB; Owen J; Kaplan KL; Sciacca RR; Cannon PJ; Nossel HL
Blood; 1982 Sep; 60(3):650-4. PubMed ID: 6179552
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.
Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R
Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273
[TBL] [Abstract][Full Text] [Related]
12. Measurement of beta-thromboglobulin and platelet factor 4 to follow up patients with artificial heart valves.
Bellon JL; Castellanos C; Acevedo L; Amiral J
Semin Thromb Hemost; 1993; 19 Suppl 1():178-82. PubMed ID: 8362264
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders.
Wehmeier A; Fricke S; Scharf RE; Schneider W
Eur J Haematol; 1990 Oct; 45(4):191-7. PubMed ID: 2146144
[TBL] [Abstract][Full Text] [Related]
14. The significance of fibrinogen derivatives in plasma in human renal failure.
Lane DA; Ireland H; Knight I; Wolff S; Kyle P; Curtis JR
Br J Haematol; 1984 Feb; 56(2):251-60. PubMed ID: 6229269
[TBL] [Abstract][Full Text] [Related]
15. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus.
Rosove MH; Frank HJ; Harwig SS
Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689
[TBL] [Abstract][Full Text] [Related]
16. In vivo platelet release in myeloproliferative disorders.
Ireland H; Lane DA; Wolff S; Foadi M
Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
[TBL] [Abstract][Full Text] [Related]
17. Platelet secretory activities in acute malaria (Plasmodium falciparum) infection.
Essien EM; Ebhota MI
Acta Haematol; 1983; 70(3):183-8. PubMed ID: 6192658
[TBL] [Abstract][Full Text] [Related]
18. Platelet alpha granule depletion: findings in patients with prosthetic heart valves and following cardiopulmonary bypass surgery.
Pumphrey CW; Dawes J
Thromb Res; 1983 May; 30(3):257-64. PubMed ID: 6191404
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the need of long-term antithrombotic therapy in patients with porcine heterograft heart valve.
Cella G; Casonato A; Schivazappa L; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):150-5. PubMed ID: 6164610
[TBL] [Abstract][Full Text] [Related]
20. Molecular markers of hemostasis activation in nephrotic syndrome.
Sagripanti A; Cupisti A; Ferdeghini M; Pinori E; Barsotti G
Nephron; 1989; 51(1):25-8. PubMed ID: 2521695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]